ArticleCancer medicine2026
Sleep, Depressive Symptoms, and Quality of Life Among Women With Newly Diagnosed Breast Cancer: Baseline Results From the AMBER Cohort Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Insomnia in Breast Cancer: A Neglected Symptom Cluster.Journal of clinical medicine · 2026Review
- Sleep, Depressive Symptoms, and Quality of Life Among Women With Newly Diagnosed Breast Cancer: Baseline Results From the AMBER Cohort Study.Cancer medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSleep problems are common among breast cancer survivors and are associated with poor quality of life. However, few studies have considered whether depressive symptoms confound or modify this association. This study evaluates whether depressive symptoms attenuate the association between sleep and quality of life in newly diagnosed breast cancer survivors.
methodsWomen with newly diagnosed early-stage breast cancer were recruited between 2012 and 2019 in Alberta, Canada, and completed the Pittsburg Sleep Quality Index (PSQI) to characterize global sleep quality and subscales. Quality of life was measured using the Short Form Survey (SF-36 version-2) to assess physical and mental well-being. Depressive symptoms were measured using the Patient Health Questionnaire (PHQ-9). Multivariable linear regressions were used to estimate the association of sleep characteristics with physical and mental well-being. Depressive symptoms were evaluated as a potential confounder and effect modifier.
resultsAmong 1454 breast cancer survivors with available data, 43% reported poor global sleep quality and 10.5% reported clinically meaningful depressive symptoms. Poor sleep quality was associated with lower physical (β = -3.0, 95% CI: -3.8 to -2.3) and mental well-being (β = -5.7, 95% CI: -6.7 to -4.7). These associations were attenuated to (β = -2.3, 95% CI: -3.1 to 1.5) and (β = -1.2, 95% CI: -2.1 to -0.3) after further adjusting for depressive symptoms. Stratified analyses showed slightly stronger associations in women with non-minimal depressive symptoms, though this association was not clinically meaningful.
conclusionThe association between sleep and quality of life was substantially attenuated after accounting for depressive symptoms. Longitudinal data are needed to clarify whether depressive symptoms confound, mediate, or modify this relationship to better guide targeted interventions in breast cancer survivorship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.